New $47m FK facility
March 3, 2014
Fresenius Kabi Australia is
establishing a new $47 million
state-of-the-art pharmaceutical
manufacturing centre in
Melbourne.
Construction is set to begin on
the manufacturing facility, which
will focus on infusion therapies,
irrigation solutions, I.V generic
drugs and compounded oncology
products.
The greenfield facility will be
built on a 40,000sqm site and will
create 120 jobs after entering full
operation.
Marking the start of construction,
Zita Peach, managing director
of Fresenius Kabi Australia &
New Zealand and executive vice
president South Asia Pacific said,
“The site will markedly change
the landscape for IV products and
oncology delivery in Australia.
“Up until now there has been
limited choice for hospitals when
it comes to choosing products that
are manufactured locally.
“This site will see products
being manufactured that have
easy handling, drug compatibility,
sterility and environmental
characteristics.”
Federal Minister for Trade &
Investment Andrew Robb said it
was welcome news for Victoria’s
high end manufacturing sector,
recognising Australia’s research
credentials and commitment to
innovation, which he said were
among the country’s strengths.
“This is one of five national
investment priorities that were
agreed at a recent meeting I
hosted with my state and territory
ministerial colleagues in trade and
investment.
“Working closely with the states
and territories, the Australian
Government will continue to
promote Australia’s strengths
in industries in which we have a
strong competitive advantage,
including where we are able to
build on Australia’s manufacturing
pedigree in market niches and
create high value, sustainable jobs
for Australians.”
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Mar 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Mar 14
